Here's the live share price of Corona Remedies along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Corona Remedies | 4.45 | 3.76 | 18.68 | 14.39 | 14.39 | 4.58 | 2.73 |
| Sun Pharmaceutical Industries | -1.60 | -4.94 | 2.15 | -1.15 | -4.45 | 19.46 | 21.13 |
| Divi's Laboratories | 1.47 | 4.25 | 3.21 | -4.48 | 5.94 | 25.21 | 10.79 |
| Torrent Pharmaceuticals | -1.62 | -2.97 | 1.61 | 13.04 | 26.00 | 36.11 | 25.98 |
| Lupin | -1.68 | 0.12 | 6.23 | 18.55 | 12.37 | 48.52 | 16.73 |
| Dr. Reddy's Laboratories | -0.14 | -2.87 | -0.05 | -4.94 | 3.55 | 8.18 | 3.19 |
| Cipla | 0.68 | 1.01 | -9.96 | -24.94 | -19.18 | 11.00 | 5.51 |
| Zydus Lifesciences | -0.85 | 7.84 | 4.88 | -7.92 | 8.86 | 21.51 | 10.94 |
| Mankind Pharma | 5.24 | 16.20 | 4.01 | -8.79 | -13.27 | 16.19 | 9.42 |
| Aurobindo Pharma | 3.14 | 10.90 | 23.84 | 29.10 | 19.41 | 34.00 | 7.40 |
| Alkem Laboratories | 0.52 | 8.93 | -2.78 | 1.36 | 11.81 | 17.77 | 14.90 |
| Glenmark Pharmaceuticals | -1.02 | 7.17 | 12.08 | 20.93 | 60.93 | 62.98 | 31.57 |
| Laurus Labs | -1.52 | 14.40 | 9.46 | 17.43 | 68.80 | 54.52 | 19.40 |
| Biocon | 2.05 | -2.64 | -4.03 | -1.30 | 7.10 | 16.61 | -2.19 |
| Abbott India | -1.99 | -0.07 | -8.10 | -15.43 | -17.86 | 4.16 | 11.02 |
| Anthem Biosciences | 3.65 | 20.25 | 24.42 | 5.22 | 3.48 | 1.15 | 0.69 |
| GlaxoSmithKline Pharmaceuticals | 2.73 | 8.43 | 3.87 | -10.42 | -11.98 | 25.40 | 11.15 |
| Ipca Laboratories | 1.51 | -2.54 | 0.55 | 17.27 | 3.43 | 21.86 | 7.29 |
| Ajanta Pharma | -3.36 | -0.34 | 2.73 | 15.51 | 3.99 | 29.50 | 18.01 |
| J B Chemicals & Pharmaceuticals | -0.10 | -5.13 | 3.96 | 15.77 | 19.37 | 23.65 | 24.21 |
Over the last one year, Corona Remedies has gained 14.39% compared to peers like Sun Pharmaceutical Industries (-4.45%), Divi's Laboratories (5.94%), Torrent Pharmaceuticals (26.00%). From a 5 year perspective, Corona Remedies has underperformed peers relative to Sun Pharmaceutical Industries (21.13%) and Divi's Laboratories (10.79%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,608.69 | 1,622.66 |
| 10 | 1,571.84 | 1,594.73 |
| 20 | 1,575.6 | 1,579.77 |
| 50 | 1,574.28 | 1,549.23 |
| 100 | 1,270.51 | 0 |
| 200 | 635.25 | 0 |
In the latest quarter, Corona Remedies remained same as its previous close in promoter holding, while DII stake increased to 7.02%, FII holding rose to 2.25%, and public shareholding moved down to 21.75% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 14,00,325 | 2.37 | 217.89 | |
| 7,00,000 | 1.1 | 108.92 | |
| 2,50,208 | 0.46 | 38.93 | |
| 2,24,290 | 0.98 | 34.9 | |
| 1,22,636 | 0.61 | 19.08 | |
| 1,16,970 | 2.12 | 18.2 | |
| 1,16,970 | 0.63 | 18.2 | |
| 1,10,000 | 2.09 | 17.12 | |
| 81,030 | 2.27 | 12.61 | |
| 78,024 | 0.65 | 12.14 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Apr 07, 2026, 11:43 PM IST IST | Corona Remedies - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 31, 2026, 01:48 AM IST IST | Corona Remedies - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Mar 07, 2026, 08:53 PM IST IST | Corona Remedies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Feb 27, 2026, 09:27 PM IST IST | Corona Remedies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Feb 17, 2026, 10:56 PM IST IST | Corona Remedies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Corona Remedies Ltd. is a Public Limited Listed company incorporated on 27/08/2004 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24231GJ2004PLC044656 and registration number is 044656. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1196.42 Cr. and Equity Capital is Rs. 61.16 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Corona Remedies is ₹1,644.00 as on Apr 22, 2026.
The Corona Remedies is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Corona Remedies is ₹10,054.72 Cr as on Apr 22, 2026.
Today’s highest and lowest price of Corona Remedies are ₹1,650.55 and ₹1,610.50.
The 52-week high/low is the highest and lowest price at which Corona Remedies stock has traded in the past 52-week or nearly a year. The 52-week high of Corona Remedies is ₹1,721.00 and 52-week low of Corona Remedies is ₹1,336.95 as on Apr 22, 2026.
The Corona Remedies has shown returns of 1.71% over the past day, 3.76% for the past month, 18.68% over 3 months, 14.39% over 1 year, 4.58% across 3 years, and 2.73% over 5 years.
P/E ratio of and PB ratio of Corona Remedies are 0.00 and 14.35 on Apr 22, 2026. While the company gives a dividend yield of 0.23 per annum.